Biopharm was founded in December 1998 to develop technology solutions and services for the biopharmaceutical manufacturing business, covering biologic products, facilities and manufacturing strategy. The company is the developer of BioSolve, the biopharmaceutical industry's most powerful set of bioprocess analysis tools. The BioSolve product range enables biopharma innovators to reduce manufacturing costs and make informed process decisions to improve profitability and ultimately patient access. The BioSolve product range helps you make well-informed decisions quickly, saving time and resources during the development and manufacture of cost-effective medicines. Gain access to impartial and industry-wide data to rationalise and de-risk your business decision-making. Unlike in-house systems, the BioSolve range accesses up-to-date information from across the biopharmaceutical sector to deliver impartial knowledge and advantage. Biopharma innovators are already optimizing their bioprocesses using BioSolve to: - Save 20% to 90% on manufacturing costs by understanding cost structures early on in their development of non-platform processes. - Reduce manufacturing costs of platform processes by 10% to 20% per year by assessing the impact of new technologies and process routes.